Identification and Validation of a Novel Immune-Related lncRNA Signature for Bladder Cancer.

Hua, Shan; Xie, Zhiwen; Wang, Wenhao; Wan, Zhong; Chen, Min; Zhao, Sheng; Jiang, Juntao

Hua, Shan; Xie, Zhiwen; Wang, Wenhao; Wan, Zhong; Chen, Min; Zhao, Sheng; Jiang, Juntao.

Afiliação

Hua S; Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xie Z; Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wang W; Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wan Z; Department of Urology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Chen M; Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhao S; Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jiang J; Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Front Oncol ; 11: 704946, 2021.

Article em En | MEDLINE | ID: mdl-34322391

Palavras-chave

checkpoint blockade therapy; long noncoding ribonucleic acids; signature; tumor-infiltrating immune cell; urinary bladder neoplasms

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google